INTELLECTUAL ABILITY IN THE DUCHENNE MUSCULAR DYSTROPHY AND DYSTROPHIN GENE MUTATION LOCATION

被引:30
|
作者
Rasic, Milic, V [1 ,2 ]
Vojinovic, D. [1 ]
Pesovic, J. [3 ]
Mijalkovic, G. [1 ]
Lukic, V [1 ]
Mladenovic, J. [1 ]
Kosac, A. [1 ]
Novakovic, I [4 ]
Maksimovic, N. [4 ]
Romac, S. [3 ]
Todorovic, S. [1 ]
Pavicevic, Savic D. [3 ]
机构
[1] Clin Neurol & Psychiat Children & Youth, Belgrade 11000, Serbia
[2] Univ Belgrade, Fac Med, Belgrade, Serbia
[3] Univ Belgrade, Fac Biol, Ctr Human Mol Genet, Belgrade, Serbia
[4] Univ Belgrade, Fac Med, Inst Human Genet, Belgrade, Serbia
关键词
Duchenne muscular dystrophy (DMD); dystrophin isoform; intellectual impairment; COGNITIVE IMPAIRMENT; MENTAL-RETARDATION; BRAIN; DP71; DMD; EXPRESSION; ISOFORM; LOCUS; DP140; AMPLIFICATION;
D O I
10.2478/bjmg-2014-0071
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Duchenne muscular dystrophy (DMD) is the most common form of muscular dystrophy during childhood. Mutations in dystrophin (DMD) gene are also recognized as a cause of cognitive impairment. We aimed to determine the association between intelligence level and mutation location in DMD genes in Serbian patients with DMD. Forty-one male patients with DMD, aged 3 to 16 years, were recruited at the Clinic for Neurology and Psychiatry for Children and Youth in Belgrade, Serbia. All patients had defined DMD gene deletions or duplications [multiplex ligation-dependent probe amplification (MLPA), polymerase chain reaction (PCR)] and cognitive status assessment (Wechsler Intelligence Scale for Children, Brunet-Lezine scale, Vineland-Doll scale). In 37 patients with an estimated full scale intelligence quotient (FSIQ), six (16.22%) had borderline intelligence (70<FSIQ <= 85), while seven (18.92%) were intellectually impaired (FSIQ <70). The FSIQ was not associated with proximal and distal mutations when boundaries were set at exons 30 and 45. However, FSIQ was statistically significantly associated with mutation location when we assumed their functional consequence on dystrophin isoforms and when mutations in the 5 '-untranslated region (5 ' UTR) of Dp140 (exons 45-50) were assigned to affect only Dp427 and Dp260. Mutations affecting Dp140 and Dp71/Dp40 have been associated with more frequent and more severe cognitive impairment. Finally, the same classification of mutations explained the greater proportion of FSIQ variability associated with cumulative loss of dystrophin isoforms. In conclusion, cumulative loss of dystrophin isoforms increases the risk of intellectual impairment in DMD and characterizing the genotype can define necessity of early cognitive interventions in DMD patients.
引用
收藏
页码:25 / 35
页数:11
相关论文
共 50 条
  • [21] Is dystrophin immunogenicity a barrier to advancing gene therapy for Duchenne muscular dystrophy?
    Gorecki, Dariusz C.
    Kalinski, Pawel
    Pomeroy, Joanna
    GENE THERAPY, 2025,
  • [22] Gene therapies that restore dystrophin expression for the treatment of Duchenne muscular dystrophy
    Jacqueline N. Robinson-Hamm
    Charles A. Gersbach
    Human Genetics, 2016, 135 : 1029 - 1040
  • [23] Immune responses to dystrophin: implications for gene therapy of Duchenne muscular dystrophy
    Ferrer, A
    Wells, KE
    Wells, DJ
    GENE THERAPY, 2000, 7 (17) : 1439 - 1446
  • [24] Gene therapies that restore dystrophin expression for the treatment of Duchenne muscular dystrophy
    Robinson-Hamm, Jacqueline N.
    Gersbach, Charles A.
    HUMAN GENETICS, 2016, 135 (09) : 1029 - 1040
  • [25] Full-length dystrophin gene therapy for Duchenne muscular dystrophy
    Duan, Dongsheng
    MOLECULAR THERAPY, 2024, 32 (09) : 2817 - 2818
  • [26] Modular flexibility of dystrophin: Implications for gene therapy of Duchenne muscular dystrophy
    Harper, SQ
    Hauser, MA
    DelloRusso, C
    Duan, DS
    Crawford, RW
    Phelps, SF
    Harper, HA
    Robinson, AS
    Engelhardt, JF
    Brooks, SV
    Chamberlain, JS
    NATURE MEDICINE, 2002, 8 (03) : 253 - 261
  • [27] ERG phenotype of a dystrophin mutation in heterozygous female carriers of Duchenne muscular dystrophy
    Fitzgerald, KM
    Cibis, GW
    Gettel, AH
    Rinaldi, R
    Harris, DJ
    White, RA
    JOURNAL OF MEDICAL GENETICS, 1999, 36 (04) : 316 - 322
  • [28] Dystrophin Immunity after Gene Therapy for Duchenne's Muscular Dystrophy
    Boennemann, Carsten G.
    Belluscio, Beth A.
    Braun, Serge
    Morris, Carl
    Singh, Teji
    Muntoni, Francesco
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (24): : 2294 - 2296
  • [29] Analysis of deletions in the dystrophin gene in patients with Duchenne muscular dystrophy in Bashkortostan
    Grinchuk, OV
    Khidiyatova, IM
    Kiselev, AV
    Magzanov, RV
    Khusnutdinova, EK
    RUSSIAN JOURNAL OF GENETICS, 1999, 35 (04) : 462 - 465
  • [30] Modular flexibility of dystrophin: Implications for gene therapy of Duchenne muscular dystrophy
    Scott Q. Harper
    Michael A. Hauser
    Christiana DelloRusso
    Dongsheng Duan
    Robert W. Crawford
    Stephanie F. Phelps
    Hollie A. Harper
    Ann S. Robinson
    John F. Engelhardt
    Susan V. Brooks
    Jeffrey S. Chamberlain
    Nature Medicine, 2002, 8 : 253 - 261